Skip to main content
. 2021 Sep 11;40:101132. doi: 10.1016/j.eclinm.2021.101132

Table 1.

Clinical parameters and morphological & functional parameters of MGs for the 3 groups of study subjects

Parameter Symptomatic groups
Normal Control P of trend value
MGD Symptomatic non-MGD
No. of subjects 195 61 56
Age, mean (SD), yrs 34.47 (11.53) 33.50 (12.36) 31.65 (9.38) 0.26
Sex, no. (%) 0.15
Female 118 (60.51) 33 (54.09) 40 (71.43)
Male 77 (39.49) 28 (45.91) 16 (28.57)
Severity, no. (%) <0.001
Grade 0 0 61 (100) 56 (100)
Grade 1 47 (24.10) 0 0
Grade 2 64 (32.82) 0 0
Grade 3 47 (24.10) 0 0
Grade 4 28 (14.36) 0 0
Grade 5 9 (4.62) 0 0
Expressibility, no. (%) <0.001
0 9 (4.62) 51 (83.61) 44 (78.57)
1 89 (45.64) 10 (16.39) 12 (21.43)
2 63 (32.31) 0 0
3 34 (17.44) 0 0
OSDI, mean (SD) 25.87 (10.56) 17.05 (6.55) 3.89 (2.77) <0.001
NI-BUT, mean (SD), s 8.80 (4.81) 12.95 (5.14) 16.25 (4.92) <0.001
MGYSS, mean (SD) 24.18 (7.12) 40.54 (6.30) 41.59 (3.93) <0.001
CFS score, mean (SD) 0.87 (0.88) 0.05 (0.22) 0.00 <0.001
ST I, mean (SD), mm 12.25 (6.24) 16.48 (6.05) 16.39 (6.65) <0.001
Morphological parameters
DI, mean (SD) 12.84 (5.77) 9.62 (2.76) 10.83 (2.87) <0.001
TI, mean (SD) 13.44 (2.77) 14.90 (3.22) 14.66 (2.46) <0.001
GA, mean (SD), % 41.07 (10.22) 47.74 (6.67) 47.25 (8.16) <0.001
Functional parameter:SI range, no (%) <0.001
SI<4.5 49 (25.13) 6 (9.84) 3 (5.36)
4.5≤SI≤6.5 95 (48.72) 42 (68.85) 43 (76.79)
SI>6.5 51 (26.15) 13 (21.31) 10 (17.86)

Abbreviations: MGs: meibomian glands; MGD: meibomian gland dysfunction; SD: standard deviation; OSDI: ocular surface disease index; NI-BUT: non-invasive tear film break-up; MGYSS: meibomian gland yield secretion score; CFS: corneal fluorescein staining score; ST I: Schirmer test I; DI: diameter deformation index; TI: tortuosity index; GA: gland area ratio, which is the ratio of all meibomian gland area to the total analysis area; SI: signal index of the glands.